REGENAFORM
Live / Applied — Extension of time to oppose received (as of 25 Mar 2026)
What this means for you
Not registered yet, but its 15 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99393213
- Mark type
- Stylized text
- Filed
- 15 Sept 2025
- Published for opposition
- 24 Feb 2026
- Attorney of record
- Sarah Otte Graber
Goods and services
- Class 005 — Pharmaceuticals: Biological bone tissue intended for subsequent implantation; Biological tissue cultures for medical use; Bone growth media consisting of biological materials for medical purposes; Bone void fillers consisting of biological materials; implants comprising of biological material, namely, bone tissue, human connective tissue, human cellular material, human tissue, and living tissue for guided tissue regeneration; biological bone grafts; Human allograft bone
Owner
- Osteogenics Biomedical, Inc., Lubbock, TX, US
- Osteogenics Biomedical, Inc., Lubbock, TX, US
Prosecution history
- 25 Mar 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Feb 2026 — PUBLISHED FOR OPPOSITION
- 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jan 2026 — ASSIGNED TO EXAMINER
- 11 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 15 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Sept 2025 — NEW APPLICATION ENTERED